SCHEMBL6953085

SCHEMBL6953085

Cc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1CC=C(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.38
TSHR P16473 2/20 0.37
ALDH1A1 P00352 7/20 0.37
KMT2A Q03164 5/20 0.37
HSD17B10 Q99714 5/20 0.37
HPGD P15428 5/20 0.37
KDM4E B2RXH2 5/20 0.37
MEN1 O00255 4/20 0.37
MAPT P10636 4/20 0.37
HTT P42858 3/20 0.37
TP53 P04637 2/20 0.37
PTPN11 Q06124 1/20 0.36
MAPK1 P28482 2/20 0.36
POLB P06746 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
RAB9A P51151 1/20 0.34
APOBEC3A P31941 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949369 0.86 MEN1 (0.43) GRM2ALDH1A1KMT2AHSD17B10HPGD
SCHEMBL6952709 0.83 GRM2 (0.42) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6945683 0.83 GRM2 (0.42) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6947600 0.83 GRM2 (0.40) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6949656 0.82 GRM2 (0.41) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6952837 0.81 GRM2 (0.43) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6947212 0.80 HPGD (0.41) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6954345 0.80 GRM2 (0.41) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6949923 0.79 GRM2 (0.42) GRM2TSHRALDH1A1KMT2AHSD17B10
SCHEMBL6949918 0.79 GRM2 (0.42) GRM2TSHRALDH1A1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed